chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fatigue; incorrectly administered 2 Pfizer Comirnaty; Received 2 Comirnaty 12 and up Vaccines instead of 1 Pfizer Covid Vaccine and 1 Flu Vaccine; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A 40-year-old male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 17Oct2023 as dose 1, 0.3 ml single (Lot number: HF9298, Expiration Date: Dec2024), in left arm and on 17Oct2023 as dose 2, 0.3 ml single (Lot number: HF9298, Expiration Date: Dec2024) at the age of 40 years, in right arm, all intramuscular for covid-19 immunisation. The patient didn't receive influenza vaccine (FLU [INFLUENZA VACCINE]). The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: bnt162b2 (1st dose), administration date: 21Apr2021, when the patient was 37-year-old, for COVID-19 immunisation; bnt162b2 (2nd dose), administration date: 19May2021, when the patient was 38-year-old, for COVID-19 immunisation; bnt162b2 (3rd dose), administration date: 20Dec2021, when the patient was 38-year-old, for COVID-19 immunisation. The following information was reported: WRONG PRODUCT ADMINISTERED (non-serious) with onset 17Oct2023, outcome "unknown", described as "Received 2 Comirnaty 12 and up Vaccines instead of 1 Pfizer Covid Vaccine and 1 Flu Vaccine"; INCORRECT DOSE ADMINISTERED (non-serious) with onset 17Oct2023, outcome "unknown", described as "incorrectly administered 2 Pfizer Comirnaty"; FATIGUE (non-serious), outcome "unknown". Additional information: NDC number of Comirnaty: 00069236210. Patient was incorrectly administered 2 Pfizer Comirnaty 12 and up vaccines today. The patient was supposed to receive the Pfizer vaccine and the flu vaccine but was given 2 Pfizer vaccines. Pharmacist expects the patient to have minimal adverse effects and he was not feeling any effects currently. This was 2 hours ago. Patient experienced normal side effects of a booster (fatigue, etc).  Follow-up (08Nov2023): Follow-up attempts are completed. No further information is expected.  Follow-up (21Nov2023): This is a spontaneous follow-up report received from the same contactable reporter(s) (Pharmacist). Updated information included: historical vaccines, vaccination facility details, new event (fatigue).
Swollen, painful, hard red bump at injection site, very painful to touch, persisting today (day 2 after shot). Slight fever and queasiness, only the first day after the shot and gone now.
Unidentifiable taste in mouth w/in 5 minutes, burning sensation bottoms of both feet w/in ten minutes, lips became numb on way home, (reside 5 minutes away) burning sensation continued to below knees within hour, dissipated during day but not completely. Similar to adverse reaction years ago to Avelox.
This case was reported by a nurse via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 53-year-old male patient who received Herpes zoster (Shingrix) (batch number Z5225, expiry date 14th April 2023) for prophylaxis. On 30th November 2021, the patient received the 1st dose of Shingrix. On 30th November 2021, unknown after receiving Shingrix, the patient experienced inappropriate dose of vaccine administered and inappropriate preparation of medication. On an unknown date, the outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were unknown. Additional details were reported as follows: The nurse reported that the patient received 2 vials containing only the adjuvant component (Diluent) of Shingrix as 1st dose instead of being reconstituted with the powder which led to inappropriate dose of vaccine administered and inappropriate preparation of medication. The reporter consented to follow up.
About four minutes after shot, l had a warm rush  or flush  Go through my body, head to toe.  Nothing else occured.  I did not report to Attendant.
Local Iz reaction left arm.  6 cm x 8 cm area of diffuse erythema overlying left deltoid.  Nontender-observe.
Rash on torso; This spontaneous case was reported by a consumer and describes the occurrence of RASH in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced RASH. On 17-Mar-2021, RASH had resolved. Not Provided.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was unknown.       Concomitant medication was not provided. Treatment medication was not provided.
4 days after the injection, I felt weary when I woke up that morning.  By 10:00 AM, I had a moderate headache that lasted the rest of the day even though I did take some Ibuprofen.  5 days after, I was extremely fatigued but able to go to work and do my daily activities but went to sleep soon after dinner.  6 days after was a repeat of the extreme fatigue but I did get through my day and went to sleep early.  Day 7, I woke up feeling great and have not had any other symptoms.
She received 1st dose of COVID vaccine on Jan 26, 2021. She waited 15 minutes without any reaction at the facility. On ride home, approximately 30-45 min after getting the dose, she noticed her tongue was visibly swollen. No swelling of lips, hive, difficulty breathing, noticeable swelling of throat, lightheadedness, fever, or diarrhea. It subsided after 30 minutes. She did not seek medical attention or have a clinical evaluation. She had soreness in her arm for 3 days but otherwise had no ongoing symptoms.
Chills; Hot flashes; Headache; Tired; Sore arm; Low grade fever (<100); This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 08Apr2021 at 10:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any medication within two weeks of the COVID-19 vaccination. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 16Mar2021 at 09:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 08Apr2021 at 22:00, the patient experienced chills, hot flashes, headache, tired, sore arm, low grade fever (less than 100). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills, hot flashes, headache, tired, sore arm, low grade fever (less than 100) were resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Adverse event includes  radiculopathy of extremity  used for injection site resulting in loss of use, pain, and limited active and passive range of motion.  Usual side effects of fever, chills and myalgia were experienced additionally for a period of 32 hours
Pt recv vax on 2/8/99; on 3/11/99 pt exp zoster. This is in follow-up to report(s) previously submitted on 05/14/1999. Information has been received from a physician concerning a 38-year-old Caucasin female who on 08-FEB-1999 was vaccinated with the first dose of VARIVAX SC in the left arm. In 1999 the patient experienced chicken pox. The patient sought unspecified medical treatment. Subsequently, the patient recovered from chicken pox. No further information is available.
Sudden onset at 7:15pm of myalgias - neck, back,  and within a few minutes started chilling and shaking and I could not stop the chills and shaking for about an hour.  I have had the influenza several times in the past and it felt just like it.  I had a headache also and felt nauseated.  I stopped eating immediately when this started - just had a very light meal of salad and 1/2 yogurt.  It took me about 30 minutes before I felt OK to go upstairs to bed and I put on a light jacket over my clothes and did not undress.  I just got under the covers and put several blankets on me.  I remember breathing faster than usual and my heart rate was up.  Finally after getting warm, I stopped shaking and I could tell a fever was coming on - it was about 8:15-8:30pm by then.  I drank some water, then waited few min, took my temperature and it was 102.2F.  I took an Ondansetron for nausea and one Aleve for the Aches/fever and went back to bed.  I was hot and cold all night - no more chills though.  Also all through the night my nose was either very runny or congested.  I slept for short intervals until getting up late this AM and my temperature had gone down to 99.6.  I am tired today but feeling better.
Pfizer BioNTech COVID-19 Vaccine EUA; Janssen COVID-19 Vaccine EUA; Moderna COVID-19 Vaccine EUA: Patient received Pfizer COVID-19 Vaccines on 03/04/2021 and 3/25/2021: Janssen COVID-19 Vaccine on 5/1/2021, and Moderna COVID-19 vaccine on 8/23/2021 and 9/20/2021.
Parents report redness and swelling from left upper thigh to knee. Resolved within 24 hours.
Pt visited the emergency room on 3/13/2020 with swollen, hot arm.  It was reported to me that the swelling was from shoulder to wrist.  Pt reports diagnosis of cellulitis.  Pt was treated outpatient.
I started having intense and frequent palpitations suddenly about 2-3 wks after the second dose. They gradually became less intense, but I am still getting them on a daily basis.
No adverse symptoms reported; the patient was vaccinated with improperly stored ROTATEQ; This spontaneous report was received from a nurse practitioner referring to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, drug reactions, allergies, medical history, and concomitant therapies provided.  On 15-NOV-2019, the patient was vaccinated with improperly stored rotavirus vaccine, live, oral, pentavalent(ROTATEQ)(strength, dose, frequency, lot # and expiration date were not reported) orally for prophylaxis. The vaccine was exposed to highest temperature excursions of above 47 degree Fahrenheit(F) / 9 degree Celsius (58F) for 28 hours. There was no previous temperature excursion. No a data logger was involved. No adverse symptoms reported.
I felt a "pop" in my head and instant excruciating pain and was rushed to ER
I had exhaustion, massive fatigue, felt like energy was zapped out of you. Widespread pain increased with fibromyalgia flare up. Didn?t have any respiratory issues. Basically, the pain and the fatigue. May have messed with my memory too where I couldn?t think as clearly. Lasted for about a month. Had a Vitamin B12 shot, and symptoms were mentioned to my doctor during this appointment.
Information has been received from a physician concerning a 9 week old (also reported as "about 2 months old") female infant who on approximately 21-SEP-2010 was vaccinated with a first dose of ROTATEQ (dose, route and lot # not reported). Concomitant therapy included other unspecified vaccines indicated for 2 month old given simultaneously. On 28-SEP-2010 "about one week after administration" the patient presented to the office with diarrhoea and fever. Supportive care was given. Diarrhoea and fever improved while on therapy. On an unspecified date the patient recovered from diarrhoea and fever. Additional information was been requested.
no adverse effect reported; the patient received improperly stored VARIVAX; This non-valid spontaneous report was received from a Certified Medical Assistance referring to multiple unspecified number of patients of unknown demographics. Information of concomitant therapy, pertinent medical history and drug reactions/allergies was not reported.  On an unknown date, the patients were vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot # N014371, expiration date 09-MAY-2019, strength, dose, frequency and route were unknown) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # R012413, expiration date 28-OCT-2019, strength, dose and route were unknown), both vaccines reconstituted with properly stored diluent and administered for prophylaxis. It was reported that the temperature excursion was noticed by the digital data logger and that the temperature excursion was for 3 hours from -9 to 8 degrees Celsius. There was no previous temperature excursion. No adverse effects were reported.  Follow-up information has been received on 28-AUG-2019. A phone call was placed to the medical assistant. The phone call was answered by the receptionist. The C.M.A was unavailable. A message was left requesting a return phone call. Additionally, a request was made for patient identifiers, lot and vaccine received and on what date.  Follow up information had been received on 29-AUG-2019. A returned phone call was received from the medical assistant. The patient was a one year old male. On 26-NOV-2018, he was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot # N014371, expiration date 09-MAY-2019, strength, dose and route were unknown) for prophylaxis.  Upon receipt of follow-up information it was determined that this case now is valid, because the patient identifier was provided.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1811USA011976: US-009507513-1908USA012348: US-009507513-1908USA012365: US-009507513-1908USA012374: US-009507513-1908USA012377:
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 17-OCT-2008, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 02-JUN-2016, the patient was treated at a medical facility for a blistering vesicular outbreak which was then diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment.  As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Headache for two days followed by 3 days of fever ad chills events, general aches.
FELT HARDER TO BREATHE WITH MASK; JOINT PAIN ALL OVER; CHILLS; FEVER; MASSIVE HEADACHE; SWEATING; This spontaneous report received from a patient concerned a 42 year old female. The patient's height, and weight were not reported. The patient's past medical history included bypass surgery, and blood clots, and concurrent conditions included non smoker. The patient experienced itching and rash when treated with heparin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, expiry: not reported) dose was not reported, administered on 07-APR-2021 15:00 to Left Arm for prophylactic vaccination. Concomitant medications included acetylsalicylic acid for drug used for unknown indication. On 08-APR-2021, the subject experienced sweating. On 08-APR-2021, the subject experienced joint pain all over. On 08-APR-2021, the subject experienced chills. On 08-APR-2021, the subject experienced fever. On 08-APR-2021, the subject experienced massive headache. On 09-APR-2021, the subject experienced felt harder to breathe with mask. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sweating, joint pain all over, chills, fever, and massive headache on 08-APR-2021, and the outcome of felt harder to breathe with mask was not reported. This report was non-serious.
Patient was standing up talking to parents, when she passed out. She did regain consciousness approximately 5 seconds later and asked "what happened". Provider immediately assessed patient, placed a pulse oximetry to finger (O2 99%, HR-78, Resp- 18). Patient denied any pain, blurred vision, dizziness, level of conciousness changes. Did complain of a headache which she reported has resolved. Patient able to answer providers questions appropriately. 911-Squad also called. Upon arrival, the first responders, also assessed patient. Parents declined patient to be taking to the hospital for further assessment. Parents did report however that patient does not like to see blood, which she bled a little after the influenza vaccine was given. They stated that that was the course of patient's passing out.
Bell's Palsy; Mild tingling in the left arm; swelling on my left cheek; musculature changes in the left jaw, left cheek and facial nerve regions of left cheek (described as feeling similar to getting an injection at the dentist to numb your mouth).; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot: 03461), via an unspecified route of administration in the left arm on 19Apr2021 at 15:45 (at the age of 41-years-old) as a single dose for COVID-19 immunization. Medical history was reported as none and the patient had no known allergies. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included loratadine/pseudoephedrine sulfate (CLARITIN- D), fish oil, and a multi-vitamin (unspecified). On 19Apr2021, within 5 minutes of the vaccination, the patient experienced mild tingling in the left arm. On 19Apr2021, the patient experienced a feeling of musculature changes in the left jaw, left cheek, and facial nerve regions of left cheek (feeling similar to getting an injection at the dentist to numb your mouth). The patient was concerned it was Bell's Palsy however only noticed swelling on the left cheek. The symptoms remained the same for 2 hours without worsening, then subsided a little. The patient was not treated for the events. Since the vaccination, the patient was not tested for COVID-19. The clinical outcome of Bell's Palsy, mild tingling in the left arm, "swelling on my left cheek", "musculature changes in the left jaw, left cheek and facial nerve regions of left cheek (described as feeling similar to getting an injection at the dentist to numb your mouth)" was resolving.
Two days after patient woke up at night with sharp stabbing pain in left side of chest, was difficult to take a breath,  and  had a feeling like heart is jumping out of chest. This persisted through the night, unable to sleep. Next day took an ibprofein and the pain was less. Did not go to the hospital for fear of contracting covid. Thought it was a pulled muscle.  It got better as days went on.  But I notice I still have heart  pounding  and shortness of breath  from time to time.
contracted COVID after getting the shot; contracted COVID after getting the shot; Penis has got smaller, considerably smaller; This is a spontaneous report from a contactable consumer. This was the second case (second patient) out of the two cases.  A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: Not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced that penis had got smaller, considerably smaller and reported stated that the patient did not seem to have any sort of protection from COVID, he had contracted it. The patient was suffering with symptoms. It was reported that patient contracted COVID after getting the shot. The outcome of events was unknown.  The lot number for the vaccine, (BNT162B2), was not provided and will be requested during follow up.
Patient came in as a walk in for COVID-19 vaccination stating that he has never received any COVID-19 vaccination prior.  After administering the vaccination,  I noticed in the immunization record that the patient received a COVID-19 vaccination on May 25, 2021.  Upon reviewing the vaccination injection note, he did receive a Janssen COVID-19 vaccination on May 25, 2021.  Reported to charge nurses.  Patient was monitored and had no adverse effects.  Pharmacist notified ID and stated to report to VAERS.  Patient stated he doesn't remember receiving any COVID-19 vaccination previously.
suspected vaccination failure; she got it again; very painful; This case was reported by a consumer via media  and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows The patient was the reporter's stepmother. The age at vaccination was not reported. The patient got the vaccine after getting the shingles low and behold, she got it again. The reporter stated it was very painful. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.
Sunday, 9/11/22, approximately 8:30  AM while driving noticed blurry vision while reading signs and then double vision when looking at traffic lights. (example, green light had second green light directly on top; same with red and yellow).  Continued until I got home (about 20 min. later). Stopped shortly after that. Also had ocular migraine later in the afternoon (which I do have occasionally). Lasted about 15 minutes.